A Study Comparing GB241 And Rituximab in Patients With B-cell Non-Hodgkin's Lymphoma
Latest Information Update: 05 Nov 2021
At a glance
- Drugs Rituximab (Primary)
- Indications Non-Hodgkin's lymphoma
- Focus Pharmacokinetics
- Sponsors Nanjing Yoko Biomedical
- 19 Mar 2021 Status changed from recruiting to completed.
- 29 Dec 2016 New trial record